A Rare Case of Postmenopausal Hirsutism Associated With a Serous Cystadenofibroma of the Ovary

Cureus · 2024 · vol. 16(6) , pp. e63077 · doi:10.7759/cureus.63077 · PMID:39055422 · PMC11269817
case-report OA: gold CC-BY-4.0
AI-generated summary by qwen3.7-flash, 2026-09-01

This case report describes a postmenopausal woman with hirsutism caused by a benign serous cystadenofibroma of the ovary, which was incidentally found alongside endometriosis and endometrial carcinoma.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-09-01 · read from full text

This case report describes a 54-year-old postmenopausal woman presenting with new-onset hirsutism and elevated testosterone levels, initially showing unremarkable ovaries on ultrasound. Subsequent MRI imaging identified a left ovarian lesion and endometrial thickening, leading to surgery that revealed a benign serous cystadenofibroma of the ovary alongside FIGO grade 1 endometrioid carcinoma. The patient’s hirsutism resolved and testosterone levels normalized after the removal of both the ovarian tumor and the uterus, suggesting the benign tumor contributed to hyperandrogenism. Relevance to endometriosis: explicitly mentioned as an incidental finding within the ovarian biopsy during the workup for hirsutism caused by an ovarian tumor.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Hirsutism in females is most commonly associated with polycystic ovarian syndrome, but can also result from congenital adrenal hyperplasia and ovarian tumors like granulosa cell tumors, Sertoli-Leydig cell tumors, and hilus cell tumors. We present a case of a 54-year-old female with hirsutism, diagnosed with ovarian cystadenofibroma. She had a history of premature ovarian failure at the age of 35 and presented with new onset chin and upper lip hair, and scalp hair loss. Labs showed elevated total testosterone, normal dehydroepiandrosterone (DHEA) and sex hormone-binding globulin (SHBG), low estradiol, and postmenopausal range anti-Mullerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin. Cytogenetic testing showed a normal XX karyotype. Initial transvaginal ultrasound revealed a thickened endometrial stripe and unremarkable ovaries. Repeat ultrasound and MRI noted persistent endometrial thickening and a solid-cystic structure in the left ovary. The patient underwent total hysterectomy, bilateral salpingo-oophorectomy, and sentinel lymph node dissection. Endometrial biopsy showed FIGO grade 1 endometrioid carcinoma, and the left ovary biopsy revealed benign serous cystadenofibroma and endometriosis. Postoperatively, hirsutism resolved and testosterone levels normalized. Hirsutism in postmenopausal women should prompt evaluation for adrenal or ovarian sources, including tumors. Ovarian tumors cause about 1% of hirsutism cases. Our case highlights the need for thorough evaluation, as benign ovarian tumors can also cause androgen excess and associated conditions like endometrial cancer.
Full text 3,896 characters · extracted from pmc · 4 sections · click to expand

Cases

A 54-year-old female G0P0SAB1 with a history of premature ovarian failure since age 35, presented with complaints of new onset chin and upper lip hair (Ferriman-Gallwey score=12), and loss of scalp hair for one year. Labs were significant for elevated total testosterone, low estradiol, and progesterone as illustrated in Table 1 . FSH: Follicle-stimulating hormone; LH: Luteinizing hormone; SHBG: Sex hormone-binding globulin; DHEA: Dehydroepiandrosterone; TSH: Thyroid-stimulating hormone; TSI: Thyroid-stimulating immunoglobulin; AM: Ante Meridiem. DHEA and SHBG were within normal limits. AMH, FSH, LH, and prolactin were within the postmenopausal range. Cytogenetic testing was ordered and revealed a normal XX karyotype with a GTG banding pattern observed in all cells. Transvaginal ultrasound revealed a thickened and echogenic endometrial stripe, with unremarkable ovaries for which close observation was recommended. Given the high suspicion of an ovarian tumor, we recommended a repeat ultrasound and MRI of the pelvis. The transvaginal ultrasound revealed persistent endometrial thickening, and a heterogenous solid and cystic structure in the left ovary. The pelvic MRI noted an endometrial mass of 6.4 x 2.2 x 4 cm and a 3 cm ovarian lesion, requiring further characterization, however bilateral adrenal gland was unremarkable. The patient underwent total hysterectomy, b/l salpingo-oophorectomy, and sentinel lymph node dissection. Endometrial biopsy showed FIGO grade 1 endometrioid carcinoma. The biopsy from the left ovary showed benign serous cystadenofibroma and endometriosis. Postoperatively, at three months, the patient had no further hirsutism, and testosterone levels normalized.

Intro

Hirsutism is defined as the excessive growth of hair in androgen-dependent parts of the body. Irrespective of the cause, hirsutism can cause significant emotional stress and mental anguish [ 1 ]. In females, hirsutism is most commonly associated with polycystic ovarian syndrome. Other causes include congenital adrenal hyperplasia, idiopathic hyperandrogenemia, idiopathic hirsutism, Cushing syndrome, hyperprolactinemia, and ovarian tumors. The classically seen tumors are granulosa cell tumor, Sertoli-Leydig cell tumor, and hilus cell tumor [ 2 , 3 ]. We present a case of a 54-year-old female who presented with hirsutism and was diagnosed with ovarian cystadenofibroma.

Discussion

Hirsutism caused by ovarian tumors accounts for approximately 1% of all cases of hirsutism [ 4 ]. Although menopause is a relatively hyperandrogenic state, the development of hirsutism or virilizing features should never be considered normal. Cystadenomas are relatively benign ovarian epithelial tumors that have rarely been implicated as the cause of hyperandrogenism [ 5 ]. Initial workup with imaging did not reveal any ovarian mass in our case, however, the endometrial thickening observed can be hypothesized to be secondary to androgen access from undiscovered mass, peripherally converting to estrogen-causing endometrial cancer. A high clinical suspicion of a testosterone-producing ovarian tumor led to repeat imaging noting an ovarian and incidental endometrial carcinoma. Surgery was curative for both hirsutism and endometrial cancer. As noted in our case report, we detected androgen excess arising from a benign epithelial tumor.

Conclusions

Hirsutism in females often comes up as a cosmetic or dermatological concern. Beyond just the negative psychological impact on the quality of life of a patient, it can be the first and only manifestation of underlying life-threatening disease. Hirsutism in females should always prompt an extensive evaluation, with a high degree of suspicion for adrenal and ovarian tumors. While malignant ovarian tumors have been highly recognized to be associated, our finding of benign tumor and recovery after the excision highlights the need for further studies in this sector.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-03T06:15:13.668130+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-09-03T06:12:35.203786+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine